Press release
Growing Sports Injuries, Demand for Cosmetic Procedures, and Technological Advancements Propel Platelet Rich Plasma (PRP) Market Growth
Platelet Rich Plasma Market
The surge in sports-related injuries, a significant driver of PRP demand, is attributed to the growing number of individuals participating in competitive sports, as well as the intense training regimens of athletes. Sports injuries, often caused by overuse or accidents, frequently require regenerative treatments to reduce pain and accelerate recovery. PRP has become a popular option for treating conditions like tendonitis, ligament sprains, and muscle tears due to its ability to promote tissue repair and decrease recovery time.
Advancements in PRP technology also play a pivotal role in the market's expansion. Innovations such as Leukocyte-depleted PRP and Gene-activated PRP (GAPRP) aim to improve the therapeutic efficacy of platelet concentrates while minimizing the side effects associated with traditional PRP methods. A recent example of such innovation is Crown Aesthetics' November 2022 launch of ProGen PRP Eclipse, a streamlined system that produces high-quality PRP, helping to simplify and standardize PRP preparation for broader use.
To avail Sample Copy of the report @ https://www.emergenresearch.com/request-sample/2877
Increased demand for cosmetic procedures has further fueled the PRP market. PRP therapy has shown promising results for non-invasive cosmetic enhancements, including skin rejuvenation and hair restoration. With its capability to improve skin texture and stimulate collagen production, PRP is gaining traction as an effective alternative to traditional cosmetic surgeries. As more research supports its efficacy in these areas, cosmetic surgeons are increasingly adopting PRP treatments to meet the demand for minimally invasive and natural-looking enhancements.
Despite this momentum, the PRP market faces challenges. The availability of alternative therapies, including physiotherapy, exercise therapy, and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), limits PRP's adoption. PRP treatments, which can be relatively costly, are sometimes viewed as secondary options to more established therapies. Additionally, regulatory barriers, which vary globally, can restrict PRP market growth as some regions still classify PRP as an investigational therapy, slowing the pathway to widespread acceptance.
Market Segmentation Highlights
The global PRP market is segmented by type, application, and end-use. In terms of PRP type, pure platelet-rich plasma (P-PRP) dominated the market in 2022, offering versatility and safety in treating a variety of conditions, including musculoskeletal disorders, sports injuries, and hair loss. P-PRP's low risk of inflammation compared to leukocyte-rich PRP (L-PRP) has driven its popularity. Meanwhile, the L-PRP segment is projected to grow steadily, particularly as ongoing research uncovers new medical applications and combination therapies with other treatments, such as stem cell therapy.
By application, the orthopedic segment led the market in 2022, bolstered by rising cases of orthopedic disorders worldwide, including osteoarthritis and tendon injuries. According to the World Health Organization (WHO), approximately 1.71 billion individuals globally are affected by orthopedic conditions, with a significant proportion of those suffering from osteoarthritis. PRP's ability to treat these conditions with fewer side effects than traditional surgeries aligns with the growing preference for minimally invasive procedures.
The cosmetic surgery segment is expected to witness the highest growth rate over the coming years, driven by the popularity of non-surgical cosmetic solutions that promote a youthful appearance without extensive downtime or recovery. As more patients seek PRP treatments for aesthetic improvements, advancements in PRP preparation and delivery techniques are likely to boost its safety and efficacy, making it an appealing option for cosmetic practitioners and patients alike.
Among end-use sectors, hospitals captured the largest share of the PRP market, supported by their specialized facilities, expertise, and resources. Hospitals are equipped with advanced infrastructure and a range of healthcare professionals, including orthopedic surgeons and plastic surgeons, who are trained to provide safe and effective PRP therapy. The multidisciplinary environment within hospitals further ensures coordinated and integrated patient care, especially for those undergoing orthopedic treatment.
As sports injuries continue to rise, interest in non-surgical cosmetic treatments grows, and PRP technology evolves, the Platelet Rich Plasma market is positioned for steady expansion. While challenges remain, PRP's unique advantages in promoting healing and supporting natural, minimally invasive treatment options underscore its promising future in the global healthcare landscape.
For More Details On this Report: @ https://www.emergenresearch.com/industry-report/platelet-rich-plasma-market
Platelet Rich Plasma Top Companies and Competitive Landscape
The global platelet rich plasma market is fairly fragmented, with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective Platelet Rich Plasma solutions.
Some major players included in the global platelet rich plasma market report are:
Johnson and Johnson Private Limited
EmCyte Corporation
Zimmer Biomet India
Arthrex, Inc.
Stryker
Celling Biosciences, Inc.
Terumo Medical Corporation
Abbott
Acon Laboratories, Inc.
Royal Biologics
Platelet Rich Plasma Latest Industry Updates
On 15 December 2022, RegenOrthoSport, an interventional orthopedic medical clinic developed a new, more concentrated, and purified form of platelet-rich plasma (PRP). This advanced PRP is produced using a specialized technique that results in a higher concentration of healing growth factors, making it more effective in stimulating the body's natural healing response. Regen OrthoSport's PRP procedures are guided by high-level imaging to ensure precise placement of PRP into the target area. PRP is commonly used to treat soft tissue injuries, mild arthritis, spine conditions, and nerve pain.
On 12 January 2022, Suneva Medical, Inc announced merger agreement with Viveon Health to create regenerative aesthetic company. Company's portfolio encompasses minimally invasive procedures that harness the body's natural healing powers to deliver immediate aesthetic improvements in non-surgical outpatient settings. PlasmaIQ, first handheld FDA-cleared plasma energy device for skin rejuvenation, Puregraft, a distinctive fat grafting system.
Buy Now: @ https://www.emergenresearch.com/select-license/2877
Platelet Rich Plasma Market Segmentation Analysis
For the purpose of this report, Emergen Research has segmented global Platelet rich plasma market on the basis of Type, Application, End-Use, and region:
Type Outlook (Revenue, USD Million; 2019-2032)
Pure platelet Rich plasma
Leukocyte Rich
Others
Application Outlook (Revenue, USD Million; 2019-2032)
Orthopedic
Arthritis
Bone repair and regeneration
Cosmetics surgery
Sports Medicine
Neurology
Cardiology
Dermatology
Plastic Surgery
Ulcer Healing
Dental
Others
End-Use Outlook (Revenue, USD Million; 2019-2032)
Hospital
Clinic
Research Institute
Others
Regional Outlook (Revenue, USD Million; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
A Journey Through Market Analysis: Exploring Related Reports
Platelet Rich Plasma Market Size @ https://www.emergenresearch.com/industry-report/platelet-rich-plasma-market/market-size
Platelet Rich Plasma Market Share @ https://www.emergenresearch.com/industry-report/platelet-rich-plasma-market/market-share
Platelet Rich Plasma Market Trends @ https://www.emergenresearch.com/industry-report/platelet-rich-plasma-market/market-trends
Platelet Rich Plasma Regional Market Demand @ https://www.emergenresearch.com/industry-report/platelet-rich-plasma-market/regional-market-demand
Platelet Rich Plasma Market Analysis @ https://www.emergenresearch.com/industry-report/platelet-rich-plasma-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growing Sports Injuries, Demand for Cosmetic Procedures, and Technological Advancements Propel Platelet Rich Plasma (PRP) Market Growth here
News-ID: 3680721 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for PRP
Therapeutic PRP Tubes Market to Witness Growth at a 6.6% CAGR by 2031 | Regen La …
QYResearch A newly published report titled "Global Therapeutic PRP Tubes Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Therapeutic PRP Tubes market. For instance, the market dynamics section digs deep into the…
Global PRP Centrifuges Market Research Report 2023-2029
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global PRP Centrifuges Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a comprehensive analysis of the global PRP Centrifuges market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides advanced statistics…
Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth.
The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence…
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023"
The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million…
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its…
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.…
